SECURITIES PURCHASE AGREEMENT AMONG BIOBLAST pharma ltd. and THE INVESTORS PARTY HERETOSecurities Purchase Agreement • March 27th, 2019 • Enlivex Therapeutics Ltd. • Pharmaceutical preparations
Contract Type FiledMarch 27th, 2019 Company IndustryTHIS SECURITIES PURCHASE AGREEMENT (this “Agreement”), dated as of March 11, 2019, is by and among BioBlast Pharma Ltd., a company formed under the laws of the State of Israel (the “Company”), and each investor identified on the signature pages hereto (each, an “Investor” and collectively, the “Investors”).